A Novel Role for High-Mobility Group A Proteins in Cellular Senescence and Heterochromatin Formation

Cell

Volumn 126, Issue 3, 2006, Pages 503-514

  Narita, Masashi ^a   Narita, Masako ^a   Krizhanovsky, Valery ^a   Nuñez, Sabrina ^a   Chicas, Agustin ^a   Hearn, Stephen A ^a   Myers, Michael P ^a   Lowe, Scott W ^a,b  

^a Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; HIGH MOBILITY GROUP A PROTEIN; PROTEIN; PROTEIN MDM2; PROTEIN P16INK4A; UNCLASSIFIED DRUG;

ARTICLE; CANCER; CARCINOGENESIS; CELL FUNCTION; CELLULAR SENESCENCE; CHROMATIN; CONTROLLED STUDY; FIBROBLAST; GENE; GENE EXPRESSION; HETEROCHROMATIN; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; PROTEIN STRUCTURE;

EID: 33746752125     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2006.05.052     Document Type: Article

References (40)

1. Baldassarre G., Fedele M., Battista S., Vecchione A., Klein-Szanto A.J., Santoro M., Waldmann T.A., Azimi N., Croce C.M., and Fusco A. Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc. Natl. Acad. Sci. USA 98 (2001) 7970-7975
2. Beausejour C.M., Krtolica A., Galimi F., Narita M., Lowe S.W., Yaswen P., and Campisi J. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 22 (2003) 4212-4222
3. Ben-Porath I., and Weinberg R.A. When cells get stressed: an integrative view of cellular senescence. J. Clin. Invest. 113 (2004) 8-13
4. Berner J.M., Meza-Zepeda L.A., Kools P.F., Forus A., Schoenmakers E.F., Van de Ven W.J., Fodstad O., and Myklebost O. HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas. Oncogene 14 (1997) 2935-2941
5. Braig M., Lee S., Loddenkemper C., Rudolph C., Peters A.H., Schlegelberger B., Stein H., Dorken B., Jenuwein T., and Schmitt C.A. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436 (2005) 660-665
6. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120 (2005) 513-522
7. Chadwick B.P., and Willard H.F. Chromatin of the Barr body: histone and non-histone proteins associated with or excluded from the inactive X chromosome. Hum. Mol. Genet. 12 (2003) 2167-2178
8. Chan H.M., Narita M., Lowe S.W., and Livingston D.M. The p400 E1A-associated protein is a novel component of the p53 → p21 senescence pathway. Genes Dev. 19 (2005) 196-201
9. Chen Z., Trotman L.C., Shaffer D., Lin H.K., Dotan Z.A., Niki M., Koutcher J.A., Scher H.I., Ludwig T., Gerald W., et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436 (2005) 725-730
10. Collado M., Gil J., Efeyan A., Guerra C., Schuhmacher A.J., Barradas M., Benguria A., Zaballos A., Flores J.M., Barbacid M., et al. Tumour biology: senescence in premalignant tumours. Nature 436 (2005) 642
11. Dillon N. Heterochromatin structure and function. Biol. Cell. 96 (2004) 631-637
12. Dimri G.P., Hara E., and Campisi J. Regulation of two E2F-related genes in presenescent and senescent human fibroblasts. J. Biol. Chem. 269 (1994) 16180-16186
13. Fedele M., Battista S., Kenyon L., Baldassarre G., Fidanza V., Klein-Szanto A.J., Parlow A.F., Visone R., Pierantoni G.M., Outwater E., et al. Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene 21 (2002) 3190-3198
14. Fedele M., Pentimalli F., Baldassarre G., Battista S., Klein-Szanto A.J., Kenyon L., Visone R., De Martino I., Ciarmiello A., Arra C., et al. Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. Oncogene 24 (2005) 3427-3435
15. Fedele M., Fidanza V., Battista S., Pentimalli F., Klein-Szanto A.J., Visone R., De Martino I., Curcio A., Morisco C., Del Vecchio L., et al. Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. Cancer Res. 66 (2006) 2536-2543
16. Harrer M., Luhrs H., Bustin M., Scheer U., and Hock R. Dynamic interaction of HMGA1a proteins with chromatin. J. Cell Sci. 117 (2004) 3459-3471
17. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37 (1965) 614-636
18. Heard E., Rougeulle C., Arnaud D., Avner P., Allis C.D., and Spector D.L. Methylation of histone H3 at Lys-9 is an early mark on the X chromosome during X inactivation. Cell 107 (2001) 727-738
19. Lanahan A., Williams J.B., Sanders L.K., and Nathans D. Growth factor-induced delayed early response genes. Mol. Cell. Biol. 12 (1992) 3919-3929
20. Lazzerini Denchi E., Attwooll C., Pasini D., and Helin K. Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland. Mol. Cell. Biol. 25 (2005) 2660-2672
21. Martinez Hoyos J., Fedele M., Battista S., Pentimalli F., Kruhoffer M., Arra C., Orntoft T.F., Croce C.M., and Fusco A. Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulation. Cancer Res. 64 (2004) 5728-5735
22. Mendez J., and Stillman B. Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol. Cell. Biol. 20 (2000) 8602-8612
23. Michaloglou C., Vredeveld L.C., Soengas M.S., Denoyelle C., Kuilman T., van der Horst C.M., Majoor D.M., Shay J.W., Mooi W.J., and Peeper D.S. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436 (2005) 720-724
24. Munshi N., Agalioti T., Lomvardas S., Merika M., Chen G., and Thanos D. Coordination of a transcriptional switch by HMGI(Y) acetylation. Science 293 (2001) 1133-1136
25. Narita M., Nunez S., Heard E., Narita M., Lin A.W., Hearn S.A., Spector D.L., Hannon G.J., and Lowe S.W. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113 (2003) 703-716
26. Nielsen S.J., Schneider R., Bauer U.M., Bannister A.J., Morrison A., O'Carroll D., Firestein R., Cleary M., Jenuwein T., Herrera R.E., and Kouzarides T. Rb targets histone H3 methylation and HP1 to promoters. Nature 412 (2001) 561-565
27. Radic M.Z., Saghbini M., Elton T.S., Reeves R., and Hamkalo B.A. Hoechst 33258, distamycin A, and high mobility group protein I (HMG-I) compete for binding to mouse satellite DNA. Chromosoma 101 (1992) 602-608
28. Reeves R. Molecular biology of HMGA proteins: hubs of nuclear function. Gene 277 (2001) 63-81
29. Reeves R., Edberg D.D., and Li Y. Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol. Cell. Biol. 21 (2001) 575-594
30. Roninson I.B. Tumor cell senescence in cancer treatment. Cancer Res. 63 (2003) 2705-2715
31. Schmitt C.A., Fridman J.S., Yang M., Lee S., Baranov E., Hoffman R.M., and Lowe S.W. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109 (2002) 335-346
32. Seger Y.R., Garcia-Cao M., Piccinin S., Cunsolo C.L., Doglioni C., Blasco M.A., Hannon G.J., and Maestro R. Transformation of normal human cells in the absence of telomerase activation. Cancer Cell 2 (2002) 401-413
33. Serrano M., Lin A.W., McCurrach M.E., Beach D., and Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88 (1997) 593-602
34. Sgarra R., Rustighi A., Tessari M.A., Di Bernardo J., Altamura S., Fusco A., Manfioletti G., and Giancotti V. Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer. FEBS Lett. 574 (2004) 1-8
35. Shelton D.N., Chang E., Whittier P.S., Choi D., and Funk W.D. Microarray analysis of replicative senescence. Curr. Biol. 9 (1999) 939-945
36. Siegel P.M., and Massague J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer 3 (2003) 807-821
37. Takaha N., Resar L.M., Vindivich D., and Coffey D.S. High mobility group protein HMGI(Y) enhances tumor cell growth, invasion, and matrix metalloproteinase-2 expression in prostate cancer cells. Prostate 60 (2004) 160-167
38. Vandel L., Nicolas E., Vaute O., Ferreira R., Ait-Si-Ali S., and Trouche D. Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase. Mol. Cell. Biol. 21 (2001) 6484-6494
39. Zhang R., Poustovoitov M.V., Ye X., Santos H.A., Chen W., Daganzo S.M., Erzberger J.P., Serebriiskii I.G., Canutescu A.A., Dunbrack R.L., et al. Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev. Cell 8 (2005) 19-30
40. Zhou X., Benson K.F., Ashar H.R., and Chada K. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376 (1995) 771-774